Hungary: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Hungary

In 2022, the Hungarian prophylactic medicaments containing insulin market decreased by -0.6% to $X, falling for the third year in a row after four years of growth. Overall, the total consumption indicated a strong increase from 2012 to 2022: its value increased at an average annual rate of +5.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -2.1% against 2019 indices. Prophylactic medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Hungary

In value terms, prophylactic medicaments containing insulin production reduced modestly to $X in 2022 estimated in export price. In general, the total production indicated a buoyant expansion from 2012 to 2022: its value increased at an average annual rate of +5.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -1.7% against 2019 indices. The pace of growth appeared the most rapid in 2016 with an increase of 21%. Over the period under review, production hit record highs at $X in 2019; however, from 2020 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Hungary

For the sixth consecutive year, Hungary recorded growth in shipments abroad of medicaments containing insulin but not antibiotics in measured doses, which increased by 9.9% to X tons in 2022. Over the period under review, total exports indicated a pronounced increase from 2012 to 2022: its volume increased at an average annual rate of +4.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +100.5% against 2016 indices. The most prominent rate of growth was recorded in 2021 when exports increased by 26% against the previous year. Over the period under review, the exports hit record highs in 2022 and are expected to retain growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports declined modestly to $X in 2022. Overall, total exports indicated notable growth from 2012 to 2022: its value increased at an average annual rate of +4.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +84.2% against 2016 indices. The most prominent rate of growth was recorded in 2021 when exports increased by 40%. As a result, the exports reached the peak of $X, and then fell in the following year.

Exports by Country

Slovenia (X tons), Romania (X tons) and Ukraine (X tons) were the main destinations of prophylactic medicaments containing insulin exports from Hungary, with a combined 88% share of total exports.

From 2012 to 2022, the biggest increases were recorded for Slovenia (with a CAGR of +42.0%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Slovenia ($X), Romania ($X) and Ukraine ($X) constituted the largest markets for prophylactic medicaments containing insulin exported from Hungary worldwide, together accounting for 87% of total exports.

Slovenia, with a CAGR of +41.0%, saw the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, shrinking by -10.7% against the previous year. Over the period under review, the export price, however, continues to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2016 an increase of 20% against the previous year. The export price peaked at $X per ton in 2021, and then contracted in the following year.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Denmark ($X per ton), while the average price for exports to Romania ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Denmark (+14.1%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Hungary

In 2022, imports of medicaments containing insulin but not antibiotics in measured doses into Hungary reached X tons, remaining constant against the previous year's figure. In general, total imports indicated a resilient increase from 2012 to 2022: its volume increased at an average annual rate of +5.8% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by -11.6% against 2020 indices. The most prominent rate of growth was recorded in 2013 with an increase of 25%. Imports peaked at X tons in 2020; however, from 2021 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports contracted to $X in 2022. Over the period under review, imports recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2017 when imports increased by 22% against the previous year. Imports peaked at $X in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

Imports by Country

France (X tons), Germany (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Hungary, with a combined 99.9% share of total imports.

From 2012 to 2022, the biggest increases were recorded for France (with a CAGR of +20.3%), while purchases for the other leaders experienced mixed trend patterns.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Hungary were France ($X), Denmark ($X) and Germany ($X), together accounting for 100% of total imports.

France, with a CAGR of +9.0%, recorded the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, reducing by -8.1% against the previous year. Over the period under review, the import price continues to indicate a noticeable setback. The pace of growth appeared the most rapid in 2017 when the average import price increased by 8.1%. Over the period under review, average import prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (-1.4%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :